Combination therapy with anti-mediator drugs in allergic disease.

about

Omalizumab, a novel anti-IgE therapy in allergic disorders.

P2860

Q34452726-17B4D8BA-CF0D-4297-B166-71FDCFAB57CE

P2860

Combination therapy with anti-mediator drugs in allergic disease.

Item

http://www.wikidata.org/entity/Q43522675

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Combination therapy with anti-mediator drugs in allergic disease.

@en

Combination therapy with anti-mediator drugs in allergic disease.

@nl

type

Item

label

Combination therapy with anti-mediator drugs in allergic disease.

@en

Combination therapy with anti-mediator drugs in allergic disease.

@nl

prefLabel

Combination therapy with anti-mediator drugs in allergic disease.

@en

Combination therapy with anti-mediator drugs in allergic disease.

@nl

P1476

Combination therapy with anti-mediator drugs in allergic disease.

@en

P2093

Rorke S

http://www.w3.org/2001/XMLSchema#string

Sampson AP

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

Leukotriene bronchoconstriction induced by allergen and exercise.

Leukotrienes in rhinitis.

Effects of a thromboxane receptor antagonist on prostaglandin D2 and histamine induced bronchoconstriction in man

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.

Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.

Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma.

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.

P304

11-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/J.1365-2222.2001.01016.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11167945

http://www.w3.org/2001/XMLSchema#string

Combination therapy with anti-mediator drugs in allergic disease.

about

P2860

P2860

Combination therapy with anti-mediator drugs in allergic disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698